Your browser doesn't support javascript.
loading
Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Giebel, Sebastian; Czyz, Anna; Ottmann, Oliver; Baron, Frederic; Brissot, Eolia; Ciceri, Fabio; Cornelissen, Jan J; Esteve, Jordi; Gorin, Norbert-Claude; Savani, Bipin; Schmid, Christoph; Mohty, Mohamad; Nagler, Arnon.
Affiliation
  • Giebel S; Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland. sgiebel@io.gliwice.pl.
  • Czyz A; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
  • Ottmann O; Institute of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Baron F; Department of Hematology, Centre Hospitalier Universitaire Sart-Tilman, University of Liege, Belgium, France.
  • Brissot E; Clinical Hematology and Cellular Therapy Department, Hospital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Ciceri F; Hematology and Bone Marrow Transplantation (BMT) Unit, San Raffaele Scientific Institute, Milan, Italy.
  • Cornelissen JJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Esteve J; Hematology Department, August Pi i Sunyer Institute for Biomedical Research, Hospital Clinic, Barcelona, Spain.
  • Gorin NC; Clinical Hematology and Cellular Therapy Department, Hospital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Savani B; Department of Hematology and Transplantation, Vanderbilt University, Nashville, Tennessee.
  • Schmid C; Department of Hematology and Oncology, Klinikum Augsburg, Ludwig-Maximilians-Universitaet, Munich, Augsburg, Germany.
  • Mohty M; Clinical Hematology and Cellular Therapy Department, Hospital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Nagler A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Cancer ; 122(19): 2941-51, 2016 10.
Article in En | MEDLINE | ID: mdl-27309127
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Philadelphia Chromosome / Hematopoietic Stem Cell Transplantation / Protein Kinase Inhibitors / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Neoplasm Recurrence, Local Type of study: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Year: 2016 Type: Article Affiliation country: Poland
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Philadelphia Chromosome / Hematopoietic Stem Cell Transplantation / Protein Kinase Inhibitors / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Neoplasm Recurrence, Local Type of study: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Year: 2016 Type: Article Affiliation country: Poland